Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (21-30 of 573) with videos related to

Pageof 58
Sort By:
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Carbapenemase-producing EnterobacteriaceaeYohei Doi, David L Paterson
Clinical Microbiology Reviews|January 18, 2005
Aspergillus infections in transplant recipientsNina Singh, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2026
Fosfomycin for Extended-Spectrum Beta-Lactamase Producers-Initial Monotherapy, Transition Therapy, Combination Therapy or Not at All?Abi Manesh, David L Paterson
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 7, 2007
Detection of plasmid-mediated class C beta-lactamasesYohei Doi, David L Paterson
Critical Care Medicine|June 22, 2007
Returning to the pre-antibiotic era in the critically ill: the XDR problemDavid L Paterson, Jeffrey Lipman
Clinical Microbiology Reviews|July 17, 2007
Setting and revising antibacterial susceptibility breakpointsJohn Turnidge, David L Paterson
Current Opinion in Pulmonary Medicine|April 9, 2005
Pulmonary fungal infectionsFernanda Silveira, David L Paterson
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamasesAndrea Endimiani, David L Paterson
Advances in Experimental Medicine and Biology|August 1, 2019
Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' PolymyxinsDavid L Paterson, Robert A Bonomo
AIDS (London, England)|July 7, 2012
Number of missed doses: why 1 × 7 does not make 7 × 1?Jean-Jacques Parienti, David L Paterson
Pageof 58

Showing results (21-30 of 573) with videos related to

Sort By:
Pageof 58
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Carbapenemase-producing EnterobacteriaceaeYohei Doi, David L Paterson
Clinical Microbiology Reviews|January 18, 2005
Aspergillus infections in transplant recipientsNina Singh, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2026
Fosfomycin for Extended-Spectrum Beta-Lactamase Producers-Initial Monotherapy, Transition Therapy, Combination Therapy or Not at All?Abi Manesh, David L Paterson
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 7, 2007
Detection of plasmid-mediated class C beta-lactamasesYohei Doi, David L Paterson
Critical Care Medicine|June 22, 2007
Returning to the pre-antibiotic era in the critically ill: the XDR problemDavid L Paterson, Jeffrey Lipman
Clinical Microbiology Reviews|July 17, 2007
Setting and revising antibacterial susceptibility breakpointsJohn Turnidge, David L Paterson
Current Opinion in Pulmonary Medicine|April 9, 2005
Pulmonary fungal infectionsFernanda Silveira, David L Paterson
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamasesAndrea Endimiani, David L Paterson
Advances in Experimental Medicine and Biology|August 1, 2019
Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' PolymyxinsDavid L Paterson, Robert A Bonomo
AIDS (London, England)|July 7, 2012
Number of missed doses: why 1 × 7 does not make 7 × 1?Jean-Jacques Parienti, David L Paterson
Pageof 58